https://www.selleckchem.com/products/ms023.html
9%) patients who received dexamethasone and 298/1129 (26.4%) patients who did not. In this group, there was a significant association between dexamethasone use and reduced mortality in the primary analysis (hazard ratio, 0.46; 95% confidence interval 0.22-0.96, P = .039). Among patients who did not require respiratory support, there was no significant association between dexamethasone use and the endpoint. In this multicentre observational study, dexamethasone use administered either orally or by intravenous injection at a cumulative dose
إعجاب
علق
شارك
